Anti-CD122 antibody restores specific CD8(+) T cell response in nonalcoholic steatohepatitis and prevents hepatocellular carcinoma growth

Nonalcoholic steatohepatitis (NASH) can lead to hepatocellular carcinoma (HCC). Although immunotherapy is used as first-line treatment for advanced HCC, the impact of NASH on anticancer immunity is only partially characterized. We assessed the tumor-specific T cell immune response in the context of...

Descripción completa

Detalles Bibliográficos
Autores principales: Lacotte, Stéphanie, Slits, Florence, Moeckli, Beat, Peloso, Andrea, Koenig, Stéphane, Tihy, Matthieu, El Hajji, Sofia, Gex, Quentin, Rubbia-Brandt, Laura, Toso, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988345/
https://www.ncbi.nlm.nih.gov/pubmed/36891258
http://dx.doi.org/10.1080/2162402X.2023.2184991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988345/
https://www.ncbi.nlm.nih.gov/pubmed/36891258
http://dx.doi.org/10.1080/2162402X.2023.2184991

Ejemplares similares